Join
Live feed
·
INSIDERFilingvia Quantisnow
Genocea Biosciences Inc. logo

SEC Form 4: Davis Thomas Andrew was granted 31,250 shares and sold $2,989 worth of shares (2,717 units at $1.10), increasing direct ownership by 70% to 69,421 units (tax liability)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GNCA (Genocea Biosciences Inc.) and more on Quantisnow.

SEC Form 4: Davis Thomas Andrew was granted 31,250 shares and sold $2,989 worth of shares (2,717 units at $1.10), increasing direct ownership by 70% to 69,421 units (tax liability) | Quantisnow